Focus: LabTech is a biotechnology company specializing in sample preparation and laboratory equipment, serving the research and diagnostic sectors. Founded in 2002 and publicly traded, the company operates from Hopkinton, Massachusetts.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow LabTech to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
No open positions listed yet. Check their careers page directly.
Help build intelligence for LabTech
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from LabTech's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Recent peer-reviewed publications with author affiliations at this company
Pharmacological stabilization of hypoxia-inducible factor 1-α dampens the interferon response and promotes glycolysis in Aicardi-Goutières syndrome.
Reversing lysosomal dysfunction restores youthful state in aged hematopoietic stem cells.
Impaired cytotoxic function and exhausted phenotype of natural killer cells in VEXAS syndrome.
Hematopoietic MyD88 orchestrates the control of gut colonization by segmented filamentous bacteria.
Induction of the ISR by AB5 subtilase cytotoxin drives type-I IFN expression in pDCs via STING activation.
Showing 5 of 10 publications
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo